Near‐Infrared Light‐Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy

Author:

Zhu Guoqing1,Zheng Pan1,Wang Man1,Xie Yulin1,Sun Qianqian1,Gao Minghong1,Li Chunxia1ORCID

Affiliation:

1. Institute of Molecular Sciences and Engineering, Institute of Frontier and Interdisciplinary Science Shandong University Qingdao 266237 P. R. China

Abstract

AbstractPyroptosis, as an inflammatory cell death, has been widely applied in tumor therapy, but its systemic adverse reactions caused by nonspecific activation still seriously hinder its application. Herein, a near‐infrared (NIR) light‐triggered thermoresponsive pyroptosis strategy is designed for on‐demand initiation of pyroptosis and synergistic tumor immunotherapy. Specifically, glucose oxidase (GOx) loaded and heat‐sensitive material p(OEOMA‐co‐MEMA) (PCM) modified mesoporous Pt nanoparticles (abbreviated as PCMPt/GOx) are prepared as the mild‐temperature triggered pyroptosis inducer. Pt nanoparticles can not only serve as nanozyme with catalase‐like activity to promote GOx catalytic reaction, but also act as photothermal agent to achieve mild‐temperature photothermal therapy (PTT) and thermoresponsive GOx release on‐demand under the irradiation of NIR light, thereby activating and promoting pyroptosis. In vitro and in vivo experiments prove that NIR light‐triggered thermoresponsive pyroptosis system exhibits excellent antitumor immunity activity as well as significantly inhibits tumor growth. The precise control of pyroptosis by NIR light as well as pyroptosis cooperated with mild‐temperature PTT for synergistically attenuated tumor immunotherapy are reported for the first time. This work provides a new method to initiate pyroptosis on demand, which is of great significance for spatiotemporally controllable pyroptosis and immunotherapy.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3